All Substitutes
Loading...
Disclaimer
Did you find this information helpful?
  Â
Natclovir 250mg Capsule
Prescription Required
Salt Composition : Ganciclovir
Manufacturer : NATCO PHARMA LTD
Origin of Medicine : India
10 Capsule(s) In A Strip
Introduction to Natclovir 250mg Capsule
Natclovir 250mg Capsule contains the active ingredient Ganciclovir. It is used to treat and prevent cytomegalovirus (CMV) infections. It is used to treat CMV infections in AIDS patients and prevent CMV infections in people who received an organ transplant from someone infected with this virus. Cytomegalovirus can affect anyone but is mainly seen in people with a weak immune system. It can affect any part of the body, including the retina at the back of the eye, causing eye problems.Â
Tell your doctor if you have kidney disorders, allergic conditions or are undergoing radiotherapy or hemodialysis before taking Natclovir 250mg Capsule. Use effective birth control during the treatment and for at least 30 days after the last dose if you are a woman or for at least 90 days after the last dose if you are a man. Ensure you inform your physician of all the medicines, including supplements and herbal medicines, you are taking before you start treatment with this medication. It should be avoided in individuals with pre-existing severe bone marrow suppression or those with low blood cell counts.
Uses of Natclovir 250mg Capsule
Natclovir 250mg Capsule is used to treat and prevent cytomegalovirus (CMV) infection.
Therapeutic Effects of Natclovir 250mg Capsule
Natclovir 250mg Capsule is an antiviral medication that exerts a therapeutic effect by inhibiting the replication of cytomegalovirus (CMV) in the body. By suppressing CMV viral activity, this medication helps to control CMV infections. It reduces the risk of disease progression, including vision loss.
Interaction of Natclovir 250mg Capsule with other drugs
Inform the doctor about all of your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Natclovir 250mg Capsule, reducing effectiveness by causing undesirable side effects.Â
More Information about Natclovir 250mg Capsule
- Store at temprature between 20°C to 25°C (68°F to 77°F).
- Keep away from moisture, heat, and light.
- It should not be frozen.
- Keep it in its original packaging.
- Keep away from children and pets.
How to consume Natclovir 250mg Capsule
Natclovir 250mg Capsules can be consumed orally. The capsules are typically taken with water, with or without food, following the prescribed dosage and frequency for oral consumption.Â
Safety Advices for Natclovir 250mg Capsule
 Â
Pregnancy
 Â
Natclovir 250mg Capsule is unsafe to use in pregnancy as it can harm the developing fetus.
 Â
Breast Feeding
 ÂNatclovir 250mg Capsule is excreted in breast milk and can harm nursing infants. Breastfeeding should be avoided to prevent any adverse effects on the infant.
 Â
Lungs
  Natclovir 250mg Capsule can adversely affect lung function. It may cause respiratory symptoms such as coughing, shortness of breath, or difficulty breathing.
 Â
Liver
  Natclovir 250mg Capsule can adversely affect liver function. It is better to take caution when using it in individuals with pre-existing liver conditions or impaired liver function. Close monitoring of liver enzymes and overall liver function is recommended during the treatment.
 Â
Alcohol
 ÂIt is generally recommended to avoid excessive alcohol consumption while taking Natclovir 250mg Capsule or any medication. Alcohol can interact with this medication and affect liver function.
 Â
Driving
  People may experience side effects, including dizziness, drowsiness, or fatigue while taking Natclovir 250mg Capsule. In that case, avoid driving or operating heavy machinery.
Side Effects of Natclovir 250mg Capsule
Natclovir 250mg Capsule causes some side effects like all medications, although not everyone will experience them.Â
Serious:
- Bone marrow suppression (decrease in blood cell counts)
- Increased risk of infections
- Anemia
- Bleeding
- Kidney toxicity
- Neurotoxicity (confusion, hallucinations, seizures, and tremors)
- Uveitis (inflammation of the uvea)
- Optic neuritis (inflammation of the optic nerve)
- Retinal detachment
Common:
- Upper respiratory tract infection
- Loss of appetite
- Headache
- Cough
- Short of breath
- Diarrhea
- Tiredness
- Fever
- Thrush and oral thrush
- Nausea
Word of Advice
If you are considering getting the Natclovir 250mg Capsule, you should be known of the potential risks and warnings associated with the vaccine. Pregnancy and breastfeeding should be avoided while taking it. Effective contraception should be used during treatment. Use it cautiously if you have any pre-existing conditions, including previous liver disease, kidney disease, or eye disorder, as it may exacerbate them. Regular blood and eye examinations are recommended during treatment. Close monitoring and appropriate management are necessary in these cases. Adherence to these precautions and regular monitoring and communication with the healthcare provider can help ensure safe and effective use.
FAQs
Q 1. Can Natclovir 250mg Capsule be used in individuals with HIV?
Natclovir 250mg Capsule can be used in individuals with HIV, particularly for treating CMV retinitis. However, it should be used under a healthcare professional's guidance, considering the individual's health status and other factors.
Q 2. Can Natclovir 250mg Capsule cause long-term fertility problems?
Natclovir 250mg Capsule has the potential to impair fertility. However, the extent and reversibility of fertility problems can vary among individuals. It is advisable to discuss concerns about fertility issues with a healthcare professional.
Q 3. Are there any specific age-related precautions for Natclovir 250mg Capsule use?
Natclovir 250mg Capsule use in elderly individuals may require closer monitoring due to age-related changes in kidney function and potential comorbidities. Pediatric use of this medication requires careful dosing adjustments based on age and weight.
Q 4. What should I do if I experience eye-related symptoms while taking Natclovir 250mg Capsule?
If you experience any eye-related symptoms, such as eye pain, redness, vision changes, or other concerning ocular effects, it is important to seek immediate medical attention. Prompt evaluation by an ophthalmologist is crucial to determine the appropriate management.
Q 5. Is there any specific of using Natclovir 250mg Capsule precautions for individuals with uveitis or optic neuritis history?
Individuals with a history of uveitis or optic neuritis should exercise caution when using Natclovir 250mg Capsule, as it can potentially worsen these conditions. Close monitoring and evaluation by an ophthalmologist are important for managing ocular effects.
Q 6. Can Natclovir 250mg Capsule be used concomitantly with other antiviral medications?
The concomitant use of Natclovir 250mg Capsule with other antiviral medications, such as didanosine, may increase the risk of toxicity.
Q 7. Are there any specific warnings for individuals with a history of blood disorders using Natclovir 250mg Capsule?
Individuals with a history of blood disorders should be closely monitored while taking Natclovir 250mg Capsule due to the potential risk of bone marrow suppression. In such cases, regular blood tests and close communication with a healthcare professional are important.
Q 8. Can Natclovir 250mg Capsule affect glucose levels or diabetes control?
Natclovir 250mg Capsule has the potential to affect glucose levels and may require close monitoring in individuals with diabetes. Regular blood glucose monitoring and consultation with a healthcare professional are recommended for appropriate diabetes management while taking it.
Fact Box of Natclovir 250mg Capsule
Molecule name: Ganciclovir | Therapeutic class: Antiviral agents |
Pharmacological class: Nucleoside analogs | Indications: Cytomegalovirus infection |
References
- Roche Products Limited, Electronic medicines compendium (EMC), [Revised on Jan 2022], [Accessed on 09/05/2022], https://www.medicines.org.uk/emc/files/pil.1641.pdf
- European medicines agency; Published on 25/02/2016; Accessed on 18/05/2023; https://www.ema.europa.eu/en/documents/referral/cymevene-article-30-referral-assessment-report_en.pdf
- Exela Pharma Sciences, US Food, and Drug Administration, [ Revised on Feb 2017] [ Accessed on 18th May 2023],https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209347lbl.pdf
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
